US Military Strike in Eastern Pacific Kills Three Amid Legal and Human Rights Concerns 
Bolivia Nears End to 50-Day Crisis After Government Reaches Deal With Workers 
U.S. Launches Trade Investigation Into Germany’s Pharmaceutical Cost-Cutting Plans 
Canada, British Columbia Launch $5 Billion Infrastructure Partnership to Boost Housing, Transit, and Healthcare 
Trump Questions USMCA Renewal as Trade Talks Continue 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
JD Vance Delays Iran Peace Talks as U.S.-Iran War Deal Faces New Uncertainty 
Israel-Hezbollah Ceasefire Takes Effect Amid Rising Tensions Over U.S.-Iran Deal 
Carney, Trump Hold Detailed Trade Talks as USMCA Future Faces Uncertainty 
Marco Rubio to Visit Gulf Nations for Key Middle East Talks 
Trump Says He Will Visit Turkey and Return to China in 2026 
Zelenskiy Backs Lula’s Peace Initiative as Ukraine Seeks New Diplomatic Path to End War 
South Korea’s Lee Jae Myung Strengthens Ties With Trump at G7 Summit, Discusses North Korea and Future Golf Meeting 
UN Clash Erupts as Israel Envoy Confronts UN Officials Over Blacklisting Reports 
Flavio Bolsonaro Unveils Tough Crime Plan Ahead of Brazil Election 
Lee Jae Myung, Trump Discuss Step-by-Step North Korea Nuclear Strategy at G7 
Trump Inspects Upgraded Qatar-Gifted Boeing 747 as Interim Air Force One Nears Service 
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
